Skip to content

A cohort study on the comparison of efficacy between ICB00 and ZCB00 intraocular lenses in pediatric cataract surgery

A cohort study on the comparison of efficacy between ICB00 and ZCB00 intraocular lenses in pediatric cataract surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116257
Enrollment
Unknown
Registered
2026-01-07
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The specific diseases targeted by this study are childhood cataracts

Interventions

Depth-of-field extension type single-focus group (ICB00 group):None
Traditional single-focus group (ZCB00 group):None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. Age 1 to 10 years old; 2. Primary IOL implantation for congenital/developmental cataracts in one or both eyes; 3. Guardians sign informed consent (prospective group); 4. Retrospective group: Children who received ZCB00 implantation from 2015 to 2023 and have complete data.

Exclusion criteria

Exclusion criteria: 1. Combined with glaucoma, corneal lesions, and retinal diseases; 2. Previous history of ocular trauma/surgery; 3. Systemic developmental disorders syndrome (such as Down syndrome); 4. Poor follow-up compliance (high expected risk of loss to follow-up).

Design outcomes

Primary

MeasureTime frame
Axial length growth rate;

Secondary

MeasureTime frame
Complication occurrence rate;Change in refractive power;Optimal correction for distance, intermediate, and near vision (BCVA, BIVA, BNVA);Convergence training is highly effective.;

Countries

China

Contacts

Public ContactLi Siyan

Eye Hospital, Wenzhou Medical University

syaine@126.com+86 18813185262

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026